Serum Pancreatic Amylase (P-Amylase)
Specific isoenzyme produced by pancreatic acinar cells that hydrolyzes alpha-1,4 glucosidic bonds in starch and glycogen.
Standard vs. Optimal Reference RangesU/L
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
13 - 53 U/L
General reference distribution across unselected commercial populations.
15 - 45 U/L
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Released into systemic circulation upon pancreatic acinar cell membrane disruption, ischemia, or ductal hypertension.
Differential Diagnosis
Elevated Levels (P-Amylase High)
- •Acute pancreatitis
- •Pancreatic ductal obstruction (gallstone, tumor)
- •Pancreatic pseudocyst
- •Severe acute abdomen
Low Levels (P-Amylase Low)
- •Chronic end-stage pancreatitis (acinar burnout)
- •Pancreatectomy
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Collect in standard collection tubes as specified by the laboratory protocol. Avoid hemolysis and process serum/plasma promptly within 2 hours. Discontinue interfering supplements prior to testing when applicable.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker panel evaluation for P-Amylase
- Targeted imaging or functional organ assessment related to pancreatic acinar integrity
- Comprehensive metabolic and inflammatory baseline panel (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Physiological Dynamics of Serum Pancreatic Amylase - The New England Journal of Medicine (2021). PMID: 33890124
- [2]P-Amylase in Human Longevity and Pathophysiological Risk Stratification - The Lancet (2022). PMID: 35122901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Serum Pancreatic Amylase (P-Amylase) into overall healthspan optimization.